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Abstract 
    In diabetic practice, continuous glucose monitoring (CGM) has been more used for glucose 
variability. Authors have reported and developed the clinical study of Low Carbohydrate Diet (LCD) 
and Calorie Restriction (CR) through Japan LCD Promotion Association (JLCDPA). A diabetic 
case is presented with normalizing glucose variability by LCD meal checked by CGM. Case is 51 
years female with type 2 diabetes mellitus (T2DM). At first visit, HbA1c was 10.0%, glucose was 
288mg/dL, BMI 39.1, GOT 16IU/mL, HDL-C 33mg/dL, Triglyceride 152mg/dL. CR meal was provided 
on day-1 to day-5 and LCD meal with 12% carbohydrate on day-6 to day-13. Average glucose value 
from CGM was 292mg/dL, 235mg/dL, 160mg/dL, 140mg/dL, 124mg/dL in day 3,5,7,9,11 respectively. 
On day-13, total Ketone bodies (T-KB) 540μmol/L (-131), Acetoacetic acid (AcAc) 86μmol/L (-55) and 
3-hydroxybutyric acid (3-OHBA) 454μmol/L (-85). Weight reduction was 5kg on day-14 and 11.2kg on 
day-70 with BMI 34.6. Thus, LCD showed a remarkable glucose-lowering effect in short term. 
FreeStyle Libre (Abbott, USA) seems to be a useful apparatus for monitoring the detailed fluctuation 
of blood glucose. These results would become fundamental and reference data and contribute to the 
LCD research development in the future. 
Introduction 
    Medical problems concerning diabetes, 
obesity and metabolic syndrome have been 
crucial and necessary to manage in many 
countries worldwide [1]. Adequate nutritional 
treatment is the fundamental therapy for those 
health problems [2]. Calorie restriction (CR) 
meal is formerly one of the standard therapy. After 
that, low carbohydrate diet (LCD) has been 
introduced to the medical and health field and was 
initiated by Atkins and Bernstein [3,4]. 
Successively, LCD has been prevalent and 
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developed widely until now. 
   
    After that, the medical evidence of LCD was 
reported by investigators [5]. They include 
Dietary Intervention Randomized Controlled 
Trial (DIRECT) Group presenting LCD efficacy 
until 2 and 4 years [5, 6]. The definition of LCD 
includes a rather wider area, and various levels 
of LCD has been tried and reported for years [7]. 
Furthermore, large scale studies concerning the 
clinical effect of LCD was presented, such as 
NIPPON DATA80 (National Integrated Project 
for Prospective Observation of Non-
communicable Disease and Its Trends in the 
Aged 1980) Research Group and the 
Prospective Urban Rural Epidemiology 
(PURE) study [8,9]. 
 
    Associated with the research development of 
LCD, there have been some changes to the 
guidelines in several international diabetic 
societies. One of the controversies would be the 
recommended HbA1c value, concerning what 
degree of strict control of glucose variability 
would be necessary [10,11]. Research 
development of LCD will contribute to the 
discussion in the future because LCD improves 
the average of blood glucose and Mean 
Amplitude of Glycemic Excursions (MAGE). 
   
    On the other hand, LCD in Japan was firstly 
introduced by Ebe, one of the authors [12]. After 
that, LCD has been gradually developed for 
diabetic patients. Furthermore, the author 
reported the important relationship among LCD, 
pregnant women, diabetes and ketone bodies 
[13]. In other words, a remarkably high level of 
blood ketone bodies were observed in pregnant 
women, neonates, placenta, and fetuses, and 
the various physiological roles of ketone bodies 
were reported [14]. 
 
    The author has continued treating many 
cases with gestational diabetic cases with LCD 
[13,14]. Through our clinical treatment and 
research, there was a new case with type 2 
diabetes mellitus (T2DM). Daily profile of blood 
glucose in the case was studied by continuous 
glucose monitoring (CGM), and it was 
remarkably improved by LCD meal for several 
days. The details of the case would be analyzed 
and reported in this article.  
  
Case Summary 
Present History:  
   The subject was 51 years old female. As past 
history, she has hypertension and allergic state 
for pollen allergy. She developed fatigue, 
sweating, frequent urination, feeling irritability 
and dizziness for some weeks. Then she 
thought the possibility of the climacteric 
syndrome in herself and she came to our clinic. 
 
    Urgent examination for diabetes showed that 
blood glucose was 288mg/dL and HbA1c was 
10.0%. She was diagnosed as type 2 diabetes 
mellitus (T2DM). 
 
Examination:  
 Physical examination showed in the following. 
Consciousness and vitals were normal. Lung, 
heart, abdomen and neurological were 
unremarkable. Her physique was stature 160cm, 
weight 100kg and body mass index (BMI) was 
39.1kg/m
2
. 
 
Chest X-ray and Electrocardiogram (ECG) 
were normal. Urinalysis showed positive for 
glucose, negative for protein. 
 
    Blood biochemistry tests were as follows: 
GOT 16 U/L, GPT 20U/L, total protein 7.1g/dL, 
BUN 15mg/dL, Cre 0.6mg/dL, T-Cho 195mg/dL, 
HDL-C 33mg/dL, Triglyceride 152mg/dL, Fe 
74μg/dL, UIBC 237μg/dL (110-425), complete 
blood count; RBC 498 x 10
4
/μl, Hb 15.9g/dL, 
WBC 7,600/μl. Others were unremarkable.  
 
Research Protocol  
     In this study, the daily profile of blood 
glucose was investigated. For measurement of 
detail fluctuation of blood glucose, FreeStyle 
Libre [15] was applied for 2 weeks [16]. This 
medical apparatus is used for Continuous 
Glucose Monitoring (CGM) [17]. After many 
years of research, it has been made and 
delivered by Abbott Diabetes Care in several 
countries [15]. 
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    For long years, authors have continued 
clinical research about LCD and CR. There 
has been a certain clinical study protocol for 
the meal of LCD and CR. CR includes the 
balance of three macronutrients with PFC ratio 
is 15:25:60. This is the standard ratio of the 
recommended meal from Japan diabetes 
Association (JDA) [18]. 
 
    In contrast, LCD meal was selected 12% of 
carbohydrate in calorie ratio, which has been 
called as super-LCD. Its definition was made 
and prevalent by Dr. Ebe et al. in Japan LCD 
Promotion Association (JLCDPA). 
 
     In this study, the subject was provided with 
the standard formula meal according to our 
research protocol. The schedule is as follows:  
I. The subject was given CR meal from 
day-1 to day-5, including 60% of 
carbohydrate which is standard meal in 
Japan as per Japan Diabetes Association 
[18]. 
II. The clock time of three meals was at 0800, 
1200, 1800h, respectively in regular 
schedule. 
III. The subject was given super-LCD meal 
from day-6 to day-13, including 12% of 
carbohydrate. 
IV. Detail glucose variability in 24 hours a day 
was continued from day-1 to day-13.  
 
Course and Results 
    Using the FreeStyle Libre, the result of CGM for 
a daily profile of blood glucose was shown in Fig-
1. Formula meal of CR was given from day-1 to 
day-5. The average blood glucose per day was 
292mg/dL on day-3, and 235mg/dL on day-5, in 
which the average data was decreasing. 
 
 
Fig-1: Daily profile of blood glucose from day 3 to 11 using CGM 
     Calorie restriction (CR) in day 1 to day 5 and Low carbohydrate diet (LCD) in day 6 to day 13 
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    On the other hand, formula meal of LCD was 
given from day-6 to day-13. The average blood 
glucose per day was 160mg/dL on day-7, 
140mg/dL on day-9, 124mg/dL on day-11, 
respectively. This data showed a remarkable 
decrease in five days. On day-11, the daily profile 
of blood glucose showed almost normal range. 
Furthermore, the fluctuation between preprandial 
and postprandial blood glucose has been 
decreasing gradually and remarkably. 
  
Blood values for ketone bodies on day-13 were 
measured, in which total ketone bodies 
540μmol/L (-131), Acetoacetic acid (AcAc) 
86μmol/L (-55), 3-hydroxybutyric acid (3-OHBA) 
454μmol/L (-85). All fragments of ketone bodies 
were elevated. 
 
    Until day-14, there were remarkable changes 
in the sign and symptom. Body weight was 
decreased to 5kgs and pretibial edema (PTE) 
was remarkably reduced until day-21. She felt 
the decrease of fatigue, hunger sensation, and 
stressful mood because of no limitation for eating 
meat and egg. Furthermore, she felt stable 
psychologically with the decreased opportunity to 
scold her children, indicating that her irritability 
was remarkably relieved. Her body weight was 
decreased to 88.8kg with BMI 34.6kg/m
2 
in day-
70, indicating clinical efficacy of LCD. 
 
Discussion and Conclusion 
    With regard to LCD, Dr. Ebe started to apply 
LCD to diabetic patients in Japan, and developed 
LCD in Japan. He has established Japan LCD 
Promotion Association (JLCDPA) and we have 
continued to give general people correct and 
useful information of LCD through lots of 
occasions such as seminars, books, and reports 
in medical societies for years [19]. 
Simultaneously, LCD often brings elevated 
hyperketonemia. The physiological role of ketone 
bodies is extremely important in clinical practice. 
In the axis of a fetus-placenta-newborn-pregnant 
mother, KB can produce necessary energy 
instead of glucose [19]. 
 
    In this study, blood levels of ketone bodies 
were measured for 7 days after starting to give 
LCD meal to the subject. As a result, blood 
values of T-KB, AcAc, and 3-OHBA were 
elevated. The level of 3-OHBA which has the 
main function of the ketone body was 5 times 
higher than the standard value in this study. 
 
    The effects of ketone bodies (KB) has been 
gradually known with lots of beneficial function 
in metabolic and other axes in man [20,21]. 
They are  
I. Elevated KB in blood is not the risky 
situation  
II. Brain and muscle can use KB similar to 
glucose 
III. KB generate much energy 
IV. KB has anti-cancer effects [22]. 
 
    Glucose intake 20-40g per day will cause 
elevation of 3-OHBA of approximately 1 mM 
(1000 μmol/L) with wide variations [23, 24]. 
 
 In the diabetic patients provided with LCD 
meal, blood values of total ketone bodies 
showed 160 to 4,000 μmol/L (0.16 to 4 
mmol/L) [25]. From this data, current total KB 
and 3-OHBA would be in the range as 
expected. 
 
 In the history of diabetes care, recently 
introduced CGM has given a big impact [26]. 
Among them, FreeStyle Libre (Abbott, USA) 
has been a useful apparatus for CGM with a 
sensor-based method for glucose monitoring 
[27]. With CGM, the frequency of 
hypoglycemia in type 1 diabetes was reduced 
[28]. Furthermore, blood glucose fluctuation 
could be revealed in type 2 diabetes [29]. 
 
    Practical data on CGM has been 
accumulated for long years. Clinical and 
Laboratory Standards Institute (CLSI) 
announced the CGM guidelines [30]. 
Furthermore, international standardization has 
continued the researches on the precision 
absolute relative difference (PARD) and mean 
absolute relative deviation (MARD) [31, 32]. 
   
    From the current data on day-3, the blood 
glucose has risen from 230mg/dL to 
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350mg/dL, and the difference between 
preprandial and postprandial glucose is 
120mg/dL. In the case of T2DM, blood glucose 
is said to increase by 3mg/dL per 1g 
carbohydrate intake. Therefore, it is presumed 
that about 40g of carbohydrate was ingested. 
On the other hand, on day-11, there is almost no 
difference between preprandial and postprandial 
glucose value. This seems to be related to 
decreased carbohydrate intake by LCD, 
increased insulin secretion response and 
decreased insulin resistance. 
 
   In summary, blood glucose decline was found 
in the patient with T2DM in a short period by 
LCD. The difference between preprandial and 
postprandial glucose, mean glucose and MAGE 
were decreased. Further, weight reduction was 
shown 11.2kgs in 10 weeks. These results 
suggest the increase of insulin secretion and a 
decrease of insulin resistance by the effect of 
LCD in a short period, with the useful data of a 
clinical application of LCD for future research. 
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